854264 PMJ001011770269216319854264Palliative MedicineMurtagh et al researcharticle2019 Original Article A brief patient proxyreported outcome measure advanced illness Validity reliability responsiveness Integrated Palliative care Outcome Scale IPOS Palliative Medicine 2019 Vol 338 1045 1057 The Authors 2019 Article reuse guidelines sagepubcomjournalspermissions httpsdoiorg1011770269216319854264 DOI 1011770269216319854264 journalssagepubcomhomepmj Christina Ramsenthaler23 Fliss EM Murtagh12 Esther I Groeneveld2 Natasha Lovell2 Johannes Denzel3 Ping Guo2 Florian Bernhardt3 Eva Schildmann3 Birgitt van Oorschot5 Farina Hodiamont3 Sabine Streitwieser3 Irene J Higginson2 Claudia Bausewein3 Steffen T Simon4 Alice Firth2 Abstract Background Few measures capture complex symptoms concerns receiving palliative care Aim To validate Integrated Palliative care Outcome Scale measure underpinned extensive psychometric development evaluating validity reliability responsiveness change Design Concurrent crosscultural validation study Integrated Palliative care Outcome Scale 1 patient selfreport 2 staff proxyreport versions We tested construct validity factor analysis knowngroup comparisons correlational analysis reliability internal consistency agreement testretest reliability responsiveness longitudinal evaluation change Settingparticipants In 376 adults receiving palliative care 161 clinicians range settings United Kingdom Germany Results We confirm threefactor structure Physical Symptoms Emotional Symptoms CommunicationPractical Issues Integrated Palliative care Outcome Scale shows strong ability distinguish clinically relevant groups total Integrated Palliative care Outcome Scale Integrated Palliative care Outcome Scale subscale scores higher reflecting problems patients unstable deteriorating versus stable Phase Illness F 151 p 0001 Good convergent discriminant validity hypothesised items subscales Edmonton Symptom Assessment System Functional Assessment Cancer Therapy General demonstrated The Integrated Palliative care Outcome Scale shows good internal consistency α 077 acceptable good testretest reliability 60 items kw 060 Longitudinal validity form responsiveness change good Conclusion The Integrated Palliative care Outcome Scale valid reliable outcome measure patient selfreport staff proxyreport versions It assess monitor symptoms concerns advanced illness determine impact healthcare interventions demonstrate quality care This represents major step forward internationally palliative care outcome measurement Keywords Outcome process assessment validation studies psychometrics reliability patientreported outcome measures palliative care symptom assessment 1 Wolfson Palliative Care Research Centre Hull York Medical School University Hull Hull UK 2 Cicely Saunders Institute Palliative Care Policy Rehabilitation Kings College London London UK 3 Department Palliative Medicine University Hospital Ludwig MaximiliansUniversity Munich Munich Germany 4 Center Palliative Medicine University Cologne Cologne Germany 5 Interdisciplinary Centre Palliative Medicine University Hospital Wuerzburg Wuerzburg Germany Corresponding author Fliss EM Murtagh Wolfson Palliative Care Research Centre Hull York Medical School University Hull Allam Medical Building Hull HU6 7RX UK Email flissmurtaghhymsacuk 1046 Palliative Medicine 338 What known topic Validated measures symptoms qualityoflife exist palliative care Symptom measures capture broader concerns advanced illness information needs family practical issues Qualityoflife measures weighted symptoms function relevant applicable faradvanced illness Few existing measures validated proxyreport version What paper adds The Integrated Palliative care Outcome Scale IPOS shown clinically meaningful good validity reliability responsiveness change Both patient selfreport staff proxyreport versions IPOS evaluated allowing maximum flexibility clinical use Implications practice IPOS comprehensive psychometrically robust measure underpinned patients report main cerns brief advanced illness This major advance palliative care outcome measurement internationally Background Healthcare systems world face major chal lenges increasing numbers older people multimorbidities growing need palliative care1 The increase chronic diseases accounting deaths globally population ageing responsible changes23 More people need palliative care3 estimates exceeding 40 millionyear worldwide1 To meet current challenges unexplained variations healthcare quality need addressed improving outcomes4 This achieved measurement individual patientcentred outcomes5 Patientreported outcome measures PROMs validated questionnaires completed patients measure perceptions health statuswellbeing6 Available PROMs tend illnessspecific710 capturing common concerns advanced illness regardless diagnosis Most PROMs focus disease control complications11 concerns patients illness One outcome measures capture range concerns prioritised advanced Palliative care Outcome Scale POS12 POS developed 15 years ago psychometrically tested1316 widely used1719 It brief personcentred outcome measure20 incorporates main concerns peo ple advanced illness prioritise21 Although evidence POS users demonstrated value practice research need refined version incorporating symptoms refin ing spiritualexistential item diverse populations aid utility2223 Having cognitively tested refined ver sion POS Integrated Palliative care Outcome Scale IPOS24 aimed evaluate validity reli ability responsiveness change patient self report staff proxyreport IPOS IPOS covers patients main concerns common symptoms patientfamily dis tress existential wellbeing sharing feelings family friends information received practical concerns timeframe 3 days inpatient settings 7 days ambulatory settings Methods We following established quality criteria25 refine validate IPOS The steps involving cognitive test ing published24 involved cultural adaption cognitive interviewing English German24 establish final IPOS languages available download wwwpospalorg Here report testing construct validity reliability responsiveness final version IPOS languages The design multicentre validation study versions IPOS patient selfreport b staff proxyreport Population settings Patients receiving palliative care consecutively recruited UK German sites UK German hospital consultation services b UK German inpatient palliative units c seven UK German community homebased palliative services Staff caring participating patients recruited Data gathered June 2014 January 2016 Murtagh et al 1047 Inclusion criteria Inclusionexclusion criteria patient participants 18 years age capacity written informed consent judged clinical team able speakread English German Exclusion cri teria patient participants follows impaired capacity unwell distressed participate judged clinical teams unable understand English German Inclusion criterion staff participants delivering care patient participant Staff participants scored research measures independently cor responding patient participant Data collection Demographicclinical information patient participants baseline included age gender ethnicity marital status living presenceabsence family caregivers performance status Australiamodified Karnofsky Performance Status AKPS26 primary diagnosis ESASr3032 Data Table 1 data collection measures collected timepoints 25 days apart patient settings 721 days apart community set tings For patient participants IPOS patient version 3day recall period Edmonton Symptom Assessment Systemrevised Functional Assessment Cancer TherapyGeneral FACTG33 collected timepoint IPOS patientversion global change question Table 13440 col lected second timepoint For staff participants staffversion IPOS Support Team Assessment Schedule STAS41 AKPS26 Phase Illness38 collected time point IPOS staffversion AKPS Phase Illness collected second time point Analysis All data independently doubleentered cross checked If stated missing data excluded pairwise analyses Descriptive statistics sample rangedistribution scores individual IPOS items IPOS subscales derived factor analy sis total scores Construct validity Structural validity We undertook confirmatory factor analysis CFA establish structural validity subscales Taking prior factor analyses account1516 contrasted 2factor 3fac tor solution We robust maximum likelihood estimation accommodate ordinal nature data42 Fit solution evaluated chisquare ratio chisquare degrees free dom confirmatory fit index TuckerLewis index root mean square error approximation RMSEA43 Contrasting models compared fit indices standardized parameter esti mates local strains low loadings high stand ard error44 b Knowngroup comparisons We hypothesized prior evidence38 Those unstable deteriorating Phase Illness higher total IPOS score symptomsconcerns ii higher physical symptom scores IPOS stable Phase Illness Those lower function AKPS iii higher total IPOS scores iv higher physical symptom scores IPOS45 Nonparametric tests checking assumptions KruskalWallis H test hypotheses ii MannWhitney U test iii iv c Convergent discriminant validity tested correlating individual IPOS items subscales respective items subscales patient reported ESASr32 FACTG33 measures Spearmans correlation coefficients associ ated pvalues We hypothesized High correlations r 070 identical near identical single items relating physicalpsy chological symptoms ESAS IPOS Midrange correlations r 05 07 total ESAS scores includes symptoms ii FACTG totalsubscale scores covering spiritual practical family issues IPOS total IPOS scores including domains symptoms Reliability Internal consistency estimated Cronbachs α IPOS total scores subscales The normally accepted threshold good internal consistency 082546 lowered 06 multidimen sional nonredundant nature IPOS47 c b Testretest reliability determined patients reporting change global change rating34 Interrater reliability assessed inde pendent patient staff ratings independent staff ratings Cohens weighted kappa κw calculated reliability statis tic proportion agreement cases staff patients ratings equal 1 1 score Spearman cor relation test association patient 1048 Palliative Medicine 338 t n e t p g n w o l l o F 2 1 s s e n l l d e c n v d h t w s t n e t p o t t n t r o p m t s o m s n m o d s n o t d n o c c f c e p s l r o f d e t p d S S O P e u d o m m o t p m y s k c b d e e f f f t s d n g n r e v o c s m e t 0 1 d e d u l c n l S O P e c S e m o c t u O e r c e v t l l P l n g r o e h T l 7 2 d e p o e v e d o s l e r e w S S O P d n S O P f o s n o s r e v f f t S d e d d s w S S O P d n S O P t s l m o t p m y s s t m o r f e s o h t d n S O P e c S l S O P I f o s n o s r e v o w t e r e r e h T e r u s e m d e t r g e t n e n o o t n e m o c t u O e r C e v t l l P e h t m o r f s m e t e h t s e n b m o c S O P I t r o p e r y x o r p f f t s d n t r o p e r f l e s t n e t p e n o g r e d n u e v h S S O P d n S O P f o s n o s r e v d e t r o p e r f f t s d n t n e t p h t o B f f t s 9 1 r o n o s r e v t n e t p 0 2 f o t s s n o c s n o s r e v S O P I e h T l n r e t n d n y t d l v d o o g w o h s s e r u s e m h t o B g n t s e t c r t e m o h c y s p e v s n e t x e r o t c F 0 2 3 1 s g n t t e s e s r e v d n 2 1 y t l b l e r t s e t e r t s e t s l l e w s 0 2 2 1 y c n e t s s n o c 5 1 e r c f o y t l u q d n g n e b l l e w l l c g o o h c y s p l s e c s b u s o w t s t s e g g u s s s y l n n e e t r u o f n e s u r o f d e t d l v d n d e t p d y l l r u t l u c d e t l s n r t n e e b s h t I 3 2 9 1 8 1 y l l n o t n r e t n d e s u y l e d w s d n 9 2 8 2 7 1 6 1 s e g u g n l s e u s s g n s s e c o r p e v t n g o c y f t n e d d n y t d l v e c f t n e t n o c d n y t l b t p e c c s s e s s o t g n w e v r e t n e v t n g o c d e d u l c n y d u t s n o t d l v S O P I s h t f o 1 e s h P s l m e b o r p n m t u o b n o t s e u q t x e t e e r f e n o s m e t n o s r e v l u t r p s l l c g o o h c y s p l c s y h p n o s m e t 7 1 s n r e c n o c d n d n y l m f h t w g n d u l c n s d e e n n o t c n u m m o c s l m e b o r p s m e t t x e t e e r f l n o t d d e n O t s r o w 4 o t t s e b 0 m o r f e c s l n I d e r o c s d n d e f c e p s e b o t s m o t p m y s l n o t d d t u o b s k s g n t r o p e r m e t l n o t d d n o s l s e r e h t n o s r e v t n e t p e h t e p y t t r e k L t n o p 5 n o s e r o c s e r y e h T t r o p p u s l c t c r p f o s m o t p m y s e h t g n s s e s s n e s u r o f d e t d l v y l e d w n e e b s h S A S E d e s v e r e h T m o r f d e r o c s l s e c s e u g o n l l u s v e n n f o s t s s n o c S A S E g n v e c e r l s t n e t p g n t u v e r o f e r u s e m e f l f o y t l u q s d e p o e v e d y l l l t n I f o y t l u q y r m r p r u o f o t n d e d v d s m e t 7 2 s e s r p m o c G T C A F 3 3 s n o t d n o c m r e t g n o l s s o r c d e t d l v y l e d w n e e b s h t t n e m t e r t r e c n c l n o t c n u F d n s m e t 6 g n e b l l e w l n o t o m E s m e t 7 g n e b t r e k L t n o p 5 n o d e r u s e m s m e t h c E s m e t 7 g n e b l l e w l l e w y l m f l c o S s m e t 7 g n e b l l e w l c s y h P s n m o d e f l g n n o t c n u f r e t t e b e t c d n s e r o c s r e h g H l e c s e p y t y l l t n I e t t e p p d n s s e n s w o r d g n e b l l e w y t e x n y t v t c s m o t p m y s n o m m o c t s o m e h t e r u s e m o t d e p o e v e d s w S A S E l s m o t p m y s e s r o w e t c d n s e r o c s r e h g H s t n e t p r e c n c n 2 3 0 3 s s e n l l e v s s e r g o r p d e c n v d h t w s t n e t p n o s s e r p e d e s u n h t e r b f o s s e n t r o h s n p g n d u l c n 0 1 0 f o s s e n e v s n o p s e r g n s s e s s r o f d e d n e m m o c e r n o t s e u q e g n h c l l b o g e g n s A l e g n h c l l r e v o t r o p e r o t s t n p c t r p t n e t p g n k s m e t e g n S l d n l c n l c e h t s s e s s o t f f t s l c n l c w o l l o t d e n g s e d l o o t d e t d l v s t I 7 3 6 3 e r c e v t l l p f o s e m o c t u o e t d e m r e t n 4 3 s e r u s e m e m o c t u o d e t r o p e r t n e t p n o t c n u m m o c l u t r p s l c o s o h c y s p l c s y h p g n r e v o c s m e t e r c e v t l l p d e t r f f t s e b l l v t s r f e h t s t n e s e r p e r S A T S l n o t p o 0 2 o t p u d n e r o c 9 g n s r p m o c t n e m s s e s s l c n l c s h e r e h t e s r o w r e t t e b t o g e v h s g n h t t h t y s u o y d u o w l s y d e e r h t t s l e h t r e v O s n r e c n o c d n s m o t p m y s r e h t n e g n h c o n n e e b 4 2 y l s u o v e r p d e t r o p e r n e e b s h s h t h t w l e n o t n e t p d e t e p m o c l s w e r u s e m e h t m o h w y b s m e t d e s d r d n t s 7 1 e h t y l n O l p e h f f t s h t w l p e h y l m f s e r u s e m S O P I l l u f e h T e r o c s l t o t S O P I e h t o t e t u b r t n o c g r o l p s o p w w w l t d o n w o d r o f e b l l v s m o t p m y s l u d v d n r o f s g n t r d n s n o t n f e d y r t n e m e p p u s l 5 3 e r C e v t l l P n t d u A l c n l C n d e b r c s e d s e h t d e s u e W s t c e p s e c v r e s d n s n r e c n o c y l m f g n n n p l d n s s e n e t u c e h t o t g n d r o c c s t n e t p l l y l s u o r e s s e s r o g e t c s s e n l l f o e s h P r e t r r e t n d o o g s w o h s t I 8 3 e r c h t l e h e t u c n o n d n e t u c b u s n l r t s u A r o f e s u e c r u o s e r f o r o t c d e r p s d e s u n e e b s h d n s d e e n e v t l l p f o y c n e g r u 9 3 8 3 s s e n l l e v s s e r g o r p d e c n v d h t w s n o t u p o p n l y t l t u l c n l c d n y t l b l e r e r u s e m m e t l e g n s s h T l n m r e t d n g n t r o r e t e d l e b t s n u l e b t s s e r o g e t c r u o f h t w s s e n l l f o e s h p t n e r r u c e h t f o f f t s y b d e d r o c e r s t x e t n o c e h t e d v o r p o t e r u s e m d e t r o p e r f f t s m e t l e g n S e h t n o d e s b s S P K A s u t t S e c n m r o f r e P y k s f o n r K d e f d o m l r t s u A e h T n o d e s b s p e t s 0 1 n 0 0 1 d n 0 n e e w t e b e r o c s e g n s A l 6 2 s s e n l l d e c n v d r o f d e t p d s t u b s u t t S e c n m r o f r e P y k s f o n r K y t v t c o t g n t e r l s k s t n o m m o c m r o f r e p o t y t l b s t n e t p l c s y h p l m r o n s e f n g s 0 0 1 f o e r o c s A e r c f l e s d n k r o w s r e b m u n g n s e r c e D e s e s d f o e c n e d v e o n h t w s e t l b s u t t s e c n m r o f r e p d e c u d e r e t c d n e r c e v t l l P d e t r g e t n I e h T l e c S e m o c t u O t n e t P r o h t o b y b d e t r o p e r y d u t s s h t n I s t n p c t r p f f t s d n t n e t p 2 T d n 1 T t y l t n e d n e p e d n S O P I d e s v e r m e t s y S t n e m s s e s s A m o t p m y S n o t n o m d E e h T 1 T t s t n p c t r p t n e t p y b d e t r o p e r y d u t s s h t n I f o t n e m s s e s s A n o t c n u F e h T l r e n e G y p r e h T r e c n C 1 T t s t n p c t r p t n e t p y b d e t r o p e r y d u t s s h t n I y b d e t r o p e r y d u t s s h t n I n o t s e u q e g n h c l b o G l 2 T t s t n p c t r p t n e t p G T C A F r S A S E t n e m s s e s s A m e T t r o p p u S e h T f f t s y b d e t r o p e r y d u t s s h t n I 1 T t s t n p c t r p S A T S e u d e h c S l f f t s y b d e t r o p e r y d u t s s h t n I 2 T d n 1 T t s t n p c t r p s s e n l l I f o e s h P y k s f o n r K d e f d o m l r t s u A s u t t S e c n m r o f r e P f f t s y b d e t r o p e r y d u t s s h t n I 2 T d n 1 T t s t n p c t r p s e c n e r e f e r d n n o t d l v d n u o r g k c B e r u s e m f o s l t e D e r u s e M s e r u s e m y d u t S l 1 e b T Murtagh et al 1049 staff independent staff ratings For inter pretation Landis Koch48 Fleiss49 crite ria k 04 fair good k 075 substantial excellent agreement Table 2 Demographic clinical characteristics patient participants n 376 Variable Patients Responsiveness change We assessed responsiveness distributionbased approach50 We compared mean changes respective standard deviations change descriptively categories change given global change rating ranging better worse dont knowcategory All analyses conducted SPSS version 24051 The R lavaan package version52 CFA A pvalue 005 considered statistically significant analyses Sample size Sample size considerations based guidelines sample sizes factor analysis53 Monte Carlo study determining sample size detect factor loadings 040 based factor analytic evidence POS1516 power 80 alpha level 005 Simulations run R simsem package54 10000 replications assum ing missing data handled information maximum likelihood approach A sample size 320 deemed sufficient modelling Results Subject characteristics In 392 patient participants recruited Screened eligible approached consented participants n 376 second n 275 timepoint completion reasons noncompletion shown Appendix Figure 1 Demographic clinical characteristics reported Table 2 Descriptive statistics distribution Table 3 shows prevalence IPOS items distribution IPOS scores missing data timepoint The range response options items Vomiting Having information Practical matters showed positive skew 10 There lit tle missing data highest percentage missing data Poor appetite 35 Family anxiety 24 Vomiting 21 Practical matters 21 Having information 19 Feeling peace 19 Structural validity identification subscales internal consistency An initial CFA conducted test unidimensionality model 17 scorable IPOS items loading Setting Hospital inpatient Hospice inpatient Hospital outpatient Community homebased Respite inpatient Missing Country Germany United Kingdom Sociodemographic details Age 65 years 65 years Gender Men Women Missing Ethnic origin White Black African Black Caribbean Asian Mixed ethnic background Missing Marital status Single Married Divorced separated Widowed Missing Having carer Living Disease factors Phase illness Stable Unstable Deteriorating Dying Missing Primary diagnosis Cancer Digestive organs Respiratory tract Genitourinary tract Breast Lymph Haematopoietic Other cancersa Noncancer n 180 72 5 95 13 11 154 222 479 191 13 253 35 29 404 596 Mean 658 median 67 157 219 SD 132 range 2093 416 584 174 187 15 342 8 4 1 21 36 208 56 57 19 202 132 164 129 52 1 30 292 82 47 63 29 15 56 57 463 497 40 91 21 11 03 56 96 553 149 152 51 537 351 436 343 138 03 80 777 218 125 168 77 40 149 152 Continued 1050 Table 2 Continued Variable Patients n COPD Stroke MND HIVAIDS Renal failure Liver failure Heart failure Otherb Missing Functional status Australiamodified Karnofsky performance status Mean SD range 050 60100 Missing IPOS completion Completed IPOS Completed IPOS family help 24 11 2 3 7 2 8 27 568 150 219 7 162 37 Completed IPOS staffc 168 64 29 05 08 19 05 22 67 SD 158 range 090 398 582 18 431 98 447 help Missing Time assessment 1 2 days 9 Mean 66 median 4 24 SD 76 range 162 COPD chronic obstructive pulmonary disease MND motor neurone disease IPOS Integrated Palliative care Outcome Scale aOther cancers comprised cancers liporal cavitypharynx skin brain central nervous CNS multiple sites bNonspecified noncancer disease cNot staff participants study latent variable As expected IPOS multidimensional measure goodnessoffit indices initial CFA sug gest adequate fit fit indices comparative fit index CFI 055 RMSEA 011 recommended cutoffs Appendix Table 1 The factor solution showed better fit twofactor solu tion standardised factor loadings Appendix Table 2 The factor Physical Symptoms comprises 10 items explains 249 variance The second factor Emotional Symptoms consists 4 items explains 123 vari ance The factor CommunicationPractical Issues contains 3 items explains 83 variance These factors use analysis subscales Physical Emotional CommunicationPractical sub scales Total subscale statistics shown Table 4 Cronbachs α 077 showing good internal consistency total scale For IPOS subscales Cronbachs α 070 068 058 respectively Palliative Medicine 338 Construct validity Oneway analysis variance supported prior hypoth esis total IPOS scores IPOS subscale scores higher patients unstable deteriorating Phase Illness compared stable Phase Illness F 151 p 0001 total IPOS F 178 57 p 0003 IPOS Physical IPOS Emotional symp toms respectively Appendix Figure 2 The total IPOS t 28 p 0006 IPOS Physical Symptoms subscale t 38 p 0001 individual IPOS items Shortness breath Weakness lack energy Drowsiness Poor mobility Family anxiety Depression Information able distinguish patients higher versus lower functional status Australiamodified Karnofsky Performance Status 60 100 vs 050 Appendix Table 5 Because skewed data comparisons run equiv alent nonparametric tests highly similar results Convergent discriminant validity assessment comprised testing series hypotheses IPOS subscales single items correlate single items subscales total scores ESAS FACTG Correlations confirmed hypothesised range mag nitude direction Appendix Tables 3 4 Reliability In 66 patients selfclassified stable timepoints This confirmed staffreported Phase Illness For 66 stable patients testretest reliability weighted kappa values showed good good agreement range 05008 items Sharing feelings family friends κ 020 Having κ 039 Feeling peace κ 043 Drowsiness κ 043 The proportion agreement score assessments generally good excellent items ones proportions 80 Table 5 Note Cohens weighted kappa calculated answer options item IPOS plus subscale total scores IPOS information For assessment interrater agreement independent staff maximum 95 matched pairs IPOS item available Agreement measured weighted Kappa scores good κ 04 11 17 IPOS items highest levels agreement achieved items Pain κ 072 Shortness breath κ 082 Nausea κ 063 Lower levels agreement observed items Weakness lack energy Drowsiness Family anxiety Sharing feelings family friends Has patient infor mation wanted Have practical matters resulting illness addressed Analysis Murtagh et al 1051 Table 3 Descriptive statistics distribution IPOS items timepoint 1 n 376 Prevalencea 95 CI Not 0 Slight 1 Moderate 2 Severe 3 Overwhelming time 4 Missing 290 146 489 422 553 649 774 Physical symptoms 1 Pain 623 2 Shortness breath 408 817 3 Weakness lack energy 4 Nausea 5 Vomiting 6 Poor appetite 7 Constipation 8 Sore dry mouth 9 Drowsiness 10 Poor mobility Emotional symptoms 11 Patient anxiety 12 Family anxiety 13 Depression 14 Feeling peace Communicationpractical issues 15 Sharing feelings 16 Information 17 Practical matters 710 848 519 721 750 835 287 574672 358458 778856 244336 110182 439539 372472 503603 601697 732816 664756 812884 469569 676766 706794 798873 241333 178 319 45 465 731 274 399 237 146 85 136 69 277 88 77 56 428 186 261 133 234 101 202 165 199 199 128 144 59 197 170 160 90 263 303 229 314 149 72 226 191 253 338 234 295 170 274 189 141 120 160 261 120 375 106 61 189 165 223 250 343 253 332 168 348 250 324 66 59 59 128 35 13 74 66 77 61 197 162 346 77 184 359 391 61 13 13 05 11 21 35 13 11 05 13 11 24 08 21 13 19 21 IPOS Integrated Palliative care Outcome Scale aPrevalence defined IPOS symptomsconcerns specified moderate severe overwhelming Table 4 Descriptive statistics distribution IPOS total subscale scores timepoint 1 n 376 Total sub scale scores items Range Mean IPOS Total Score IPOS Physical symptoms IPOS Emotional symptoms IPOS Communication Practical Issues 17 10 4 3 350 133 016 012 274 158 81 34 SD 93 61 36 27 Skew 05 01 16 64 αa 77 70 68 58 Eigenvalue variance 35 17 12 249 123 83 IPOS Integrated Palliative care Outcome Scale aCronbachs alpha coefficient internal reliability standard error measurement items low levels agreement showed errors items close 1 point IPOS The comparison staff patient ratings yielded similar results acceptable good agreement κ 03 achieved 11 17 IPOS items highest levels agreement Pain Shortness breath Vomiting Constipation Again items Having information κ 002 Have practical matters addressed κ 010 Sharing feelings family friends κ 013 showed low levels agree ment items Drowsiness κ 011 Feeling peace κ 026 Sore dry mouth κ 025 Table 3 However proportion scores score perfect match high 70 items Drowsiness 606 Sore dry mouth 651 The proportion agreement patient staff ratings higher second assessment Appendix Table 7 Responsiveness Table 6 presents mean changes IPOS total score relation patients global report change SD base line total IPOS score 92 Mean change scores total score large 43 improved group larger 96 group described worse However associ ated standard deviations change comparably potential misclassification large pointing 1052 Palliative Medicine 338 Table 5 Reliability assessment weighted kappa κw proportion agreement score testretest reliability inter rater agreement independent staff ratings interrater agreement patient staff ratings timepoint 1 IPOS Item Testretest Interrater Two staff Interrater patientstaff Pain Shortness breath Weakness lack energy Nausea Vomiting Poor appetite Constipation Sore dry mouth Drowsiness Poor mobility Patient anxiety Family anxiety Depression Feeling peace Sharing feelings Information Practical matters Total IPOS IPOS Physical Symptoms IPOS Emotional Symptoms IPOS CommunicationPractical Issues N 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 κww 049 078 054 075 062 065 069 079 043 071 064 060 065 043 020 039 055 081 076 067 044 818 924 864 940 894 894 894 909 773 864 803 879 833 773 697 758 833 864 894 803 682 n 92 91 92 91 90 89 86 85 88 91 95 54 90 82 70 77 59 29 94 95 88 κww 072 082 025 063 061 046 041 049 021 046 044 027 052 045 034 014 020 064 057 045 023 913 923 848 945 922 820 802 847 807 835 874 815 867 829 800 701 779 793 819 642 670 n 348 345 350 346 342 339 342 343 350 348 347 283 348 330 308 332 317 209 355 351 347 κww 059 062 029 046 054 034 047 025 011 042 035 034 038 026 013 002 010 039 039 038 013 871 861 823 812 883 749 775 651 606 744 752 792 759 724 688 702 685 694 721 644 545 IPOS Integrated Palliative care Outcome Scale Table 6 Mean total IPOS score changes T1T2 global change scale negative change scores indicates deterioration Total IPOS Things got Much better A little better No change I dont know A little worse Much worse n 28 90 55 3 24 5 Meanchange SDchange 43 61 30 75 17 67 23 135 03 81 96 80 IPOS Integrated Palliative care Outcome Scale according global change criterion Overall change 5 points total IPOS score represents mod erate effect size Discussion IPOS valid reliable outcome measure use people advanced illness It good structural valid ity underlying factors physical symptoms emotional symptoms communicationpractical issues Unusually validation study included high proportion people poor functional status strength ening conclusions advanced illness population IPOS discriminates clearly different palliative Phases Illness3839 The physical symptom subscale discriminates poor high functional status Almost individual IPOS items good agree ment retested stable patients There accepta ble good agreement patient selfreported staff proxyreported items Most importantly total IPOS score showed change keeping patient report overall change symptoms concerns direction size change The changing age distribution population increasing prevalence multimorbidities complex health needs55 require outcome measures work conditions advanced illness56 Only measures reflect patient priorities support truly patientcentred approach care57 Until outcome measures extending symptoms qualityoflife population lacking Healthrelated quality oflife measures heavily based physical function low sensitivity large floorceiling effects advanced multimorbid disease cap ture main priorities affected5864 The IPOS features set apart come measures commonly context advanced disease Including symptoms concerns affected individual distinct characteris tic commonly sought qualityoflife symptom Murtagh et al 1053 tools65 The ESAS31 MD Anderson Symptom Inventory MDASI66 Symptom Distress Scale67 Palliative Problem Severity Score PCPSS38 focus severity symptoms With exception PCPSS score physi cal psychological symptoms excluding concerns family issues family anxiety sharing feelings family friends spirituality practical issues information needs communication concerns5864 While existing tools wellvalidated416771 proxy reported versions established7273 IPOS capture impact symptoms concerns dif ferently In terms overall validity performance new refined IPOS comparable original POS similar measures field In original POS valida tion12 midrange correlations EORTC QLQC30 physi cal nonphysical qualityoflife subscales reported Midrange correlations apparent comparison POS Rotterdam Symptom Checklist74 Italian POS FACITSP EORTC QLQC15Pal55 POSS Rotterdam checklist MDASI EORTC measures125574 validation study comparing IPOS FACTG ESAS This result midrange high correlations likely existing scales largely focus severity symptoms POS IPOS focus person affected In line comparison POS pain item Brief Pain Inventorys pain impairment item yielded higher correlation Pain Severity item74 The midrange correlations 050 aspects psychological wellbeing questionnaires demonstrate different dimensions included IPOS covering wider issues spiritual family wellbeing The consistently low correlations communicationpracti cal items outcome measures studies point uniqueness aspect12557475 The second distinct feature validation IPOS broader testing reliability In terms testretest reliability good good agreement weighted kappa values 050080 These values higher similar studies testretest reliability POS12557475 ESAS317076 explained external criterion judge stability assuming stability 2448 h assumption justified fastchanging palliative population58 However items IPOS Sharing feelings fam ily friends Having information Feeling peace Drowsiness showed agreement These items showed low agreement comparison patient staff ratings This consistent prior stud ies biases affecting proxy assessments77 sug gest systematic overestimation physical symptoms underestimation psychological wellbeing informa tion needs7881 The low agreement information item observed studies POS Higginson Gao82 reported weighted kappa value low 004 item results Dawber et al78 Van Soest Poortvliet et al83 similar A study Palliative care Problem Severity Index38 identified features raters new staff member new patient patient charac teristics communication problems drowsiness family characteristics lacking interaction family impeding agreement This result observed study looking proxy ratings McGill Quality Life questionnaire79 These features present IPOS validation study Fluctuating symp toms particular drowsiness contribute demonstrated comparable ESAS item8485 This validation crosscultural conducted countries simultaneously believe strength ened cognitive development measure24 fullscale validation Despite skewness dis tributions individual items parametric non parametric statistics showed highly similar robust results terms correlations test differ ences However limitations population studied 15 patient participants noncancer conditions IPOS needs tested noncan cer conditions refinements different diseases required Indeed development version use cognitive impairment dementia way86 The use consecutive enrolment ensured IPOS validated broadly clinically representative group However selection bias ruled This valida tion mirrored conditions IPOS use clinical prac tice controlled use instance absence specific staff training prior implementation87 Despite incorporation global criterion change possible derive values minimal clinically important change improvement deterioration total IPOS subscales individual items Such feature desirable optimal cutoffs individual symptoms particular trigger specific clinical actions referral palliative care team help triage patients services88 extend clini cal research utility outcome measure728990 Clinical research implications This study demonstrated IPOS valid reliable Because brief underpinned symptoms concerns people advanced illness invalu able clinical practice research To implement measure routine clinical practice needs training A recent survey use ESAS showed range train ing needs barriers85 We working best ways implement national Outcomes Assessment Complexity Collaborative United Kingdom This based wellestablished Australian Palliative Care Outcomes Collaborative91 1054 Conclusion The IPOS valid reliable outcome measure use people advanced illness patient self report staff proxyreport versions It suitable assessing monitoring symptoms concerns advanced illness monitoring change time determin ing impact healthcare interventions demon strating quality care This invaluable clinical care audit research represents major step ward advanced illness internationally outcome measurement Acknowledgements Our thanks participants Fern Brookes proofreading formatting Especial thanks patient public involvement group work relevant people advanced illness Palliative Medicine 338 16913 University Hospital Cologne No14198 All par ticipants gave written consent including consent publica tion anonymised findings formal Distress Protocols adhered Funding The authors disclosed receipt following financial sup port research authorship andor publication article This study funded National Institute Health Research Programme Grant Applied Research CCHANGE project RPPG121012015 The views opinions expressed authors necessarily reflect National Health Service National Institute Health Research MRC CCF NETSCC National Institute Health Research Programme Grants Applied Research programme Department Health Social Care Supplemental material Supplemental material article available online Authors contributions Title measure IJH developed validated original POS CB translated culturally adapted validated German POS based original English POS FM CB IJH developed IPOS conceived validation study led protocol study FM IJH led grant application funding EIG AF ES CB FM drafted submitted ethical approvals input IJH EIG AF NL ES STS JD FB BO FH SS provided critical input pro tocol undertook data collection CR undertook main analyses critical input IJH FM CB FM CR drafted paper authors read refined pro vided critical input revisions manuscript approved final manuscript CB IJH equal cosen ior authors Availability data The datasets generated andor analysed current study publicly available protect confidentiality aggregated data available corresponding author reasonable request The IPOS POS measures freely available wwwpospalorg92 Declaration conflicting interests The authors declared following potential conflicts inter est respect research authorship andor publication article IJH developed validated original POS CB translated culturally adapted validated German version POS Otherwise authors declare competing interests Ethics consent Ethical approval study granted United Kingdom Dulwich National Research Ethics Committee London UK Reference Number 124991 Germany Local Research Ethics Committee Munich University No The Palliative care Outcome Scale called The Patient Outcome Scale appropriate context use ORCID iDs Fliss EM Murtagh httpsorcidorg0000000312893726 Christina Ramsenthaler 1818 httpsorcidorg000000029996 Alice Firth httpsorcidorg0000000307260502 Natasha Lovell httpsorcidorg000000016594799X Eva Schildmann httpsorcidorg0000000197569954 References 1 World Health Organization Strengthening palliative care component integrated treatment life course J Pain Palliat Care Pharmacother 2014 282 130134 2 Christensen K Doblhammer G Rau R et al Ageing popula tions challenges ahead Lancet 2009 3749696 1196 1208 3 GBD 2013 Mortality Causes Death Collaborators Global regional national agesex specific allcause causespecific mortality 240 causes death 19902013 systematic analysis Global Burden Disease Study 2013 Lancet 2015 3859963 117171 4 Porter ME Teisberg EO Redefining health care cre ating valuebased competition results Boston MA Harvard Business School Press 2006 5 EppingJordan JE Pruitt SD Bengoa R et al Improving quality health care chronic conditions Qual Saf Health Care 2004 134 299305 6 Dawson J Doll H Fitzpatrick R et al The routine use patient reported outcome measures healthcare settings BMJ 2010 340 c186 Murtagh et al 1055 7 Hays RD Spritzer KL Fries JF et al Responsiveness minimally important difference patientreported outcomes measurement information PROMIS 20item physical functioning short form prospective observational study rheumatoid arthritis Ann Rheum Dis 2015 741 104107 8 Gilbert A SebagMontefiore D Davidson S et al Use patientreported outcomes measure symptoms health related quality life clinic Gynecol Oncol 2015 1363 429439 9 Dur M Sadlonova M Haider S et al Health determining concepts important people Crohns disease coverage patientreported outcomes health wellbeing J Crohns Colitis 2014 81 4555 10 Berg SK Svanholm J Lauberg A et al Patientreported comes hospital discharge Heart Centres national crosssectional survey registerbased followup DenHeart study protocol BMJ Open 2014 45 e004709 11 Mak KS van Bommel AC Stowell C et al Defining stand ard set patientcentred outcomes lung cancer Eur Respir J 2016 483 852860 12 Hearn J Higginson IJ Development validation core outcome measure palliative care palliative care outcome scale Qual Health Care 1999 84 219227 13 Dzingina M Higginson IJ McCrone P et al Development patientreported palliative carespecific health classifica tion POSE Patient 2017 103 353365 14 Higginson IJ Donaldson N Relationship palliative care outcome scales Health Qual Life Outcomes 2004 2 68 15 Siegert RJ Gao W Walkey FH et al Psychological quality care factoranalytic examination palliative care outcome scale J Pain Symptom Manage 2010 401 6774 16 Harding R Selman L Simms VM et al How analyze palli ative care outcome data patients SubSaharan Africa international multicenter factor analytic examination APCA African POS J Pain Symptom Manage 2013 454 746752 17 Harding R Selman L Agupio G et al Validation core outcome measure palliative care Africa APCA African Palliative Outcome Scale Health Qual Life Outcomes 2010 8 10 18 Bausewein C Le Grice C Simon S et al The use common palliative outcome measures clinical care research systematic review POS STAS Palliat Med 2011 254 304313 19 Collins ES Witt J Bausewein C et al A systematic review use Palliative Care Outcome Scale Support Team Assessment Schedule Palliative Care J Pain Symptom Manage 2015 506 842853e19 20 Aspinal F Hughes R Higginson IJ A users guide Palliative care Outcome Scale London Palliative Care Policy Publications 2002 21 Solano JP Gomes B Higginson IJ A comparison symptom prevalence far advanced cancer AIDS heart disease chronic obstructive pulmonary disease renal disease J Pain Symptom Manage 2006 311 5869 22 Higginson IJ Simon ST Benalia H et al Which questions commonly multidimensional palliative care patient reported outcome measures useful Results European African PRISMA survey BMJ Support Palliat Care 2012 21 3642 23 Harding R Simon ST Benalia H et al The PRISMA Symposium 1 outcome tool use Disharmony European outcomes research palliative advanced disease care tools practice J Pain Symptom Manage 2011 424 493500 24 Schildmann EK Groeneveld EI Denzel J et al Discovering hidden benefits cognitive interviewing languages phase validation study Integrated Palliative care Outcome Scale Palliat Med 2016 306 599610 25 Terwee CB Bot SD deBoer MR et al Quality criteria proposed measurement properties health status questionnaires J Clin Epidemiol 2007 601 3442 26 Abernethy AP ShelbyJames T Fazekas BS et al The Australian modified Karnofsky Performance Status AKPS scale revised scale contemporary palliative care clini cal practice BMC Palliat Care 2005 41 7 27 Murphy EL Murtagh FE Carey I et al Understanding symp toms patients advanced chronic kidney disease managed dialysis use short patientcompleted assessment tool Nephron Clin Pract 2009 1111 c74c80 28 Bausewein C Fegg M Radbruch L et al Validation clini cal application German version palliative care outcome scale J Pain Symptom Manage 2005 301 5162 29 Eisenchlas JH Harding R Daud ML et al Use pallia tive outcome scale Argentina crosscultural adaptation validation study J Pain Symptom Manage 2008 352 188202 30 Bruera E Kuehn N Miller MJ et al The Edmonton Symptom Assessment System ESAS simple method assess ment palliative care patients J Palliat Care 1991 72 69 31 Chang VT Hwang SS Feuerman M Validation Edmonton Symptom Assessment Scale Cancer 2000 889 21642171 32 Watanabe SMNC Beaumont C Johnson L et al A multi centre comparison numerical versions Edmonton Symptom Assessment System palliative care patients J Pain Symptom Manage 2011 41 456468 33 Cella D Tulsky DS Gray G et al The Functional Assessment Cancer Therapy Scale development validation general measure J Clin Oncol 1993 113 570579 34 Jaeschke R Singer J Guyatt GH Measurement health status ascertaining minimal clinically important differ ence Control Clin Trials 1989 104 407415 35 Higginson I Audit methods validation inpatient use In Higginson I ed Clinical audit palliative care Oxford Radcliffe Medical Press 1993 pp 4854 36 Higginson I The development validity reliability practicality new measure palliative care Support Team Assessment Schedule PhD thesis University College London London 1992 httpdiscoveryucl acuk13178891296225pdf accessed 23 June 2015 37 Higginson I McCarthy M Validity Support Team Assessment Schedule staffs ratings reflect patients families Palliat Med 1993 7 219228 38 Masso M Allingham SF Banfield M et al Palliative Care Phase interrater reliability acceptability national study Palliat Med 2015 291 2230 1056 Palliative Medicine 338 39 Mather H Guo P Firth A et al Phase illness palliative care crosssectional analysis clinical data commu nity hospital hospice patients Palliat Med 2018 322 404412 40 Guyatt GH Norman GR Juniper EF et al A critical look transition ratings J Clin Epidemiol 2002 559 900908 41 Higginson IJ McCarthy M Validity support team assessment schedule staffs ratings reflect patients families Palliat Med 1993 73 219228 42 Satorra A Bentler PM Corrections teststatistics standard errors covariance structure analysis In von Eye A Clogg CC eds Latent variable analysis applications developmental research Thousand Oaks CA SAGE pp 399419 43 Bentler PM Comparative fit indices structural models Psychological Bulletin 107 238246 44 Brown TA Confirmatory factor analysis applied research New York London The Guilford Press 2006 45 Osborne TR Ramsenthaler C Schey SA et al Improving assessment quality life clinical care myeloma patients development validation Myeloma Patient Outcome Scale MyPOS BMC Cancer 2015 15 280 46 Fayers PM Machin D Scores measurements valid ity reliability sensitivity In Fayers P ed Quality life assessment analysis interpretation patient reported outcomes 2nd ed Chichester John Wiley Sons 2007 pp 77108 47 Vet HCW Terwee CB Mokkink LB et al Field testing item reduction data structureIn Vet HCW Terwee CB Mokkink LB et al eds Measurement medicine Cambridge Cambridge University Press 2011 pp 6595 48 Landis R Koch GG The measurement observer agreement categorical data Biometrics 1977 331 159174 49 Fleiss JL Measuring nominal scale agreement raters Psychol Bull 1971 765 378382 50 Crosby RD Kolotkin RL Williams GR Defining clinically meaningful change healthrelated quality life J Clin Epidemiol 2003 565 395407 51 SPSS Inc SPSS Windows Version 240 Armonk NY IBM Corporation 2016 52 Rosseel Y lavaan R package structural equation modelling J Stat Software 2012 482 136 53 Bentler PM Chou C Practical issues structural mod elling Sociol Method Res 1987 16 78117 54 Pornprasertmanit S Miller P Schoemann A et al simsem simulated structural equation modeling R package 2016 httpwwwcranrprojectorg accessed 1 May 2018 55 Costantini M Rabitti E Beccaro M et al Validity reliability responsiveness change Italian palliative care outcome scale multicentre study advanced cancer patients BMC Palliat Care 2016 15 23 56 Currow DC Allingham S Yates P et al Improving national hospicepalliative care service symptom outcomes atically pointofcare data collection structured feedback benchmarking Support Care Cancer 2015 232 307315 57 Higginson IJ Hart S Koffman J et al Needs assessment palliative care appraisal definitions approaches J Pain Symptom Manage 2007 335 500505 58 Higginson IJ Carr AJ Measuring quality life quality life measures clinical setting BMJ 2001 3227297 12971300 59 Heyland DK Dodek P Rocker G et al What matters endoflife care perceptions seriously ill patients family members CMAJ 2006 1745 627633 60 Lynn J Teno JM Phillips RS et al Perceptions family members dying experience older seriously ill patients Ann Intern Med 1997 1262 97106 61 Singer PA Martin DK Kelner M Quality endoflife care patients perspectives JAMA 1999 2812 163168 62 Steinhauser KE Clipp EC McNeilly M et al In search good death observations patients families provid ers Ann Intern Med 2000 13210 825832 63 Teno JM Casey VA Welch LC et al Patientfocused family centered endoflife medical care views guidelines bereaved family members J Pain Symptom Manage 2001 223 738751 64 Teno JM Clarridge BR Casey V et al Family perspectives endoflife care place care JAMA 2004 2911 8893 65 Osborne TR Ramsenthaler C Siegert RJ et al What issues matter people multiple myeloma measuring A systematic review qual ity life tools Eur J Haematol 2012 896 437457 66 Cleeland CS Mendoza TR Wang XS et al Assessing symp tom distress cancer patients MD Cancer 2000 897 16341646 67 McCorkle R Young K Development symptom dis tress scale Cancer Nurs 1978 15 373378 68 Miyasaki JM Long J Mancini D et al Palliative care advanced Parkinson disease interdisciplinary clinic new scale ESASPD Parkinsonism Relat Disord 2012 18Suppl 3 S6S9 69 Davison SN Jhangri GS Johnson JA Longitudinal valida tion modified Edmonton Symptom Assessment System ESAS haemodialysis patients Nephrol Dial Transplant 2006 2111 31893195 70 Aoun SM Monterosso L Kristjanson LJ et al Measuring symptom distress palliative care psychometric proper ties Symptom Assessment Scale SAS J Palliat Med 2011 143 315321 71 Aktas A Walsh D Kirkova J The psychometric prop erties cancer multisymptom assessment instruments clinical review Support Care Cancer 2015 237 21892202 72 Hui D Bruera E The Edmonton Symptom Assessment System 25 years later past present future develop ments J Pain Symptom Manage 2017 533 630643 73 Nekolaichuk C Watanabe S Beaumont C The Edmonton Symptom Assessment System 15year retro spective review validation studies 19912006 Palliat Med 2008 222 111122 74 PelayoAlvarez M PerezHoyos S AgraVarela Y Reliability concurrent validity Palliative Outcome Scale Rotterdam Symptom Checklist Brief Pain Inventory J Palliat Med 2013 168 867874 75 Sleeman KE Higginson IJ A psychometric validation brief measures assess palliative need patients severely affected multiple sclerosis J Pain Symptom Manage 2013 463 406412 Murtagh et al 1057 76 Dong Y Chen H Zheng Y et al Psychometric validation Edmonton Symptom Assessment System Chinese patients J Pain Symptom Manage 2015 505 712717e2 77 McPherson CL AddingtonHall JM Judging quality care end life proxies provide reliable infor mation Soc Sci Med 2003 561 95109 78 Dawber R Armour K Ferry P et al Comparison infor mal caregiver named nurse assessment symptoms elderly patients dying hospital palliative come scale BMJ Support Palliat Care Epub ahead print 12 January 2016 doi101136bmjspcare201500850 79 Jones JM McPherson CJ Zimmermann C et al Assessing agreement terminally ill cancer patients reports quality life family caregiver palliative care physician proxy ratings J Pain Symptom Manage 2011 423 354365 80 Crocker TF Smith JK Skevington SM Family profes sionals underestimate quality life diverse cultures health conditions systematic review J Clin Epidemiol 2015 685 584595 81 Roydhouse JK Wilson IB Systematic review car egiver responses patient healthrelated quality life adult cancer care Qual Life Res 2017 268 19251954 82 Higginson IJ Gao W Caregiver assessment patients advanced cancer concordance patients effect burden positivity Health Qual Life Outcomes 2008 6 42 83 Van SoestPoortvliet MC vanderSteen JT Zimmerman S et al Psychometric properties instruments measure quality endoflife care dying longterm care residents dementia Qual Life Res 2012 214 671684 84 Bergh I Kvalem IL Aass N et al What answer mean A qualitative study palliative cancer patients interpret respond Edmonton Symptom Assessment System Palliat Med 2011 257 716724 85 CarliButtenschoen D Stephan J Watanabe S et al Health care providers use knowledge Edmonton Symptom Assessment System ESAS need improve information training Support Care Cancer 2014 221 201208 86 EllisSmith C Evans CJ Murtagh FE et al Development caregiverreported measure support systematic assessment people dementia longterm care Integrated Palliative care Outcome Scale Dementia Palliat Med 2017 317 651660 87 Evans CJ Benalia H Preston NJ et al The selection use outcome measures palliative endoflife care research MORECare international consensus work shop J Pain Symptom Manage 2013 466 925937 88 Dhiliwal S Salins N Deodhar J et al Pilot testing tri age coding homebased palliative care Edmonton Symptom Assessment Scale Indian J Palliat Care 2016 221 1924 89 Hui D Shamieh O Paiva CE et al Minimal clinically impor tant differences Edmonton Symptom Assessment Scale cancer patients prospective study Cancer 2015 121 30273035 90 Hui D Shamieh O Paiva CE et al Minimal clinically important difference physical emotional total symptom distress scores Edmonton Symptom Assessment System J Pain Symptom Manage 2016 512 262269 91 Australian Palliative Care Outcomes Collaborative Australian Health Services Research Institute University Wollongong Australia 2007 httpsahsriuoweduau pcocindexhtml accessed 15 October 2018 92 POS family measures Cicely Saunders Institute Kings College London 2018 wwwpospalorg accessed 15 October 2018